{"url_path":"/sec/bglc/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003242-index.html","accession_number":"0001477932-26-003242","cik":"0001737523","ticker":"BGLC","issuer_name":"BioNexus Gene Lab Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737523/0001477932-26-003242-index.html","primary_entity_key":"0001737523","primary_entity_name":"BioNexus Gene Lab Corp"},"word_count":19,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n \n\nSee Item 1 - Legal Proceedings of this Part II above.\n\n \n\n \n\n43\n\n*Table of Contents*"}